Abstract:Acute myocardial infarction is a sudden and high-mortality disease that can be accurately diagnosed by measuring the level of cardiac troponin I in the blood. Currently, cTnI commonly used clinical detection methods usually have excellent sensitivity and are suitable for large-scale sample detection analysis. However, most of these methods are operated through multiple steps of fixation, incubation, reaction and separation, and most of them require professionals to operate complex instruments, which greatly limits their applicability in real-time rapid detection. Therefore, a method that requires low professional skills and can perform rapid detection is necessary. We presents an alternative strategy to quantify cTnI in clinical serum samples using a combination of SERS and magnetic molecularly imprinted polymers (MMIP). MMIPs was synthesized under Polyvinyl Pyrrolidone (PVP) conditions without vinyl modification using characteristic peptide as template, MAA and DMAm as functional monomers. The internal Raman probe 4-MBA was connected through Ag-SH bonds in MMIPs to solve the problem that the target object had no Raman characteristic peak. MMIPs with high magnetic and adsorptive properties showed characteristic absorption peaks at the Raman shift of 1582 cm- 1 after specific capture of the target templates. The Raman signals of the 4-MBA were reduced due to shielding effects and the detection range of this method was 0.001-100 ng mL-1. The recoveries and relative standard deviations (RSDs) of the spiked experiments were 103.1%-106.3 % and 3.54 %-7.38 %, respectively. In summary, this work had appropriate sensitivity and specificity, and there was no significant difference in detection results after ELISA verification. It provided a flexible and practical analysis method for detecting cTnI based on SERS technology. In addition, the imprinting materials of other disease markers can be prepared by changing the template molecules, which provides a new idea for the detection of other biomarkers.

Expression of cTnI Specific Antigen Sites and Antibodies Detection

[Development, Identification and Application of 33 Monoclonal Antibodies Against Cardiac Troponin T].

Two Desired Epitopes of Ctni Benefit for Preparation of Standardized Monoclonal Antibodies.

Preparation of anti-cardiac troponin I monoclonal antibodies and their characterization with surface plasmon resonance biosensor

The Impact of Antibody Selection on the Detection of Cardiac Troponin I.

Construction , Expression of Ctni(28-110Aa)-linker-tnc Fusion Protein and Its Identification

The Expression of Human Ctni and Ctnc in E.coli Andtheir Combination Assay

An Optical Immunosensor Based on Surface Plasmon Resonance for Human cTnI Determination

Aptamer-Based Fluorescent Assay for Sensitive Detection of Cardiac Troponin I

Preparation of monoclonal antibodies against troponin I and development of one-step sandwich ELISA

Cloning and Expression of Human Fetal Cardiac Troponin T Isoform

A Novel Sandwich Immunosensing Method for Measuring Cardiac Troponin I in Sera.

Establishment of chemiluminescence enzyme immunoassay for detecting human cardiac troponin I

Development of a novel ssDNA aptamer targeting cardiac troponin I and its clinical applications

Establishment and Identification of Hybridoma Cell Lines Secreting Anti-human Myocardial Troponin T Antibody

Label-Free Liquid Crystal Aptamer Sensors Based on Single-Stranded Nucleic Acid π-Structures for Detecting cTnI

A Sensitive Raman Spectroscopy Sensor for Determination Cardiac Troponin I Based on Proteolytic Peptide Magnetic Imprinting Technology

Antigen Design in Production of Anti-Human Cardiac Troponin Ⅰ Monoclonal Antibody

Determination of Cardiac Troponin I for the Auxiliary Diagnosis of Acute Myocardial Infarction by Anodic Stripping Voltammetry at a Carbon Paste Electrode.

Development of a Low Density Colorimetric Protein Array for Cardiac Troponin I Detection

[Quantitative Analysis of Serum Troponin I and Myoglobin in Patients with Acute Myocardial Infarction].